A retrospective study assessing the optimal sequencing for trifluridine/tipiracil and regorafenib in patients with metastatic colorectal cancer
Latest Information Update: 23 Aug 2021
At a glance
- Drugs Regorafenib (Primary) ; Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 23 Aug 2021 New trial record
- 03 Jul 2021 Results presented at the 23rd World Congress on Gastrointestinal Cancer